( NYSE:ABT )

News from Abbott A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

21 Jun, 2017, 09:00 ET Abbott Hosts Conference Call for Second-Quarter Earnings

Abbott (NYSE: ABT) will announce its second-quarter 2017 financial results on Thursday, July 20, 2017, before the market opens. The announcement...


09 Jun, 2017, 10:15 ET Abbott Declares 374th Consecutive Quarterly Dividend

The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 26.5 cents per share. This marks the 374th consecutive...


09 May, 2017, 09:00 ET Abbott Announces CE Mark for TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™

Abbott (NYSE: ABT) today announced CE Mark of the TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™, developed to make it easier for...


08 May, 2017, 09:00 ET Abbott Announces CE Mark and First Use of the World's First Smartphone Compatible Insertable Cardiac Monitor

Abbott (NYSE: ABT) today announced CE Mark and first use of the new Confirm Rx™ Insertable Cardiac Monitor (ICM), the world's first smartphone...


08 May, 2017, 06:00 ET Abbott Announces National Reimbursement for FreeStyle® Libre in France, Providing Access to Revolutionary Technology for People with Diabetes

Abbott today announced that the French Health Ministry has granted national reimbursement across France for FreeStyle® Libre—Abbott's revolutionary...


26 Apr, 2017, 08:00 ET Abbott Introduces Science-Based Nutrition Drinks to Help Patients Have a Better Recovery from Surgery

More than 48 million surgeries happen in the U.S. each year,1 and for many of those patients, food is off the table in the hours prior to their...


19 Apr, 2017, 07:45 ET Abbott Reports First-Quarter 2017 Results

Abbott (NYSE: ABT) today announced financial results for the first quarter ended March 31, 2017. - Reported diluted EPS from continuing...


14 Apr, 2017, 06:00 ET Abbott and Alere Amend Terms of Merger Agreement

Abbott (NYSE: ABT) and Alere Inc. (NYSE: ALR) announced today that the companies have agreed to amend the existing terms of their agreement for...


22 Mar, 2017, 09:00 ET Abbott Hosts Conference Call for First-Quarter Earnings

Abbott (NYSE: ABT) will announce its first-quarter 2017 financial results on Wednesday, April 19, 2017, before the market opens. The...


19 Mar, 2017, 14:00 ET Late-Breaking Data Shows the CardioMEMS HF System is Effective in Reducing Heart Failure Hospitalizations and Cost of Care

New late-breaking featured clinical research presented today adds strong clinical support for Abbott's CardioMEMS™ HF System as an effective...


18 Mar, 2017, 12:30 ET Late-Breaking Data on Abbott's MitraClip® System Show Continued Benefit for People with Mitral Regurgitation, Most Common Heart Valve Disease

Abbott (NYSE: ABT) today announced favorable one-year outcomes from the largest study of real-world experience for the MitraClip system in...


08 Mar, 2017, 16:15 ET Abbott to Present at Barclays Capital 2017 Global Healthcare Conference

Abbott (NYSE: ABT) will present at the Barclays Capital Global Healthcare Conference on Thursday, March 16, 2017. Brian Yoor, executive vice...


08 Mar, 2017, 09:00 ET New Study Results May Lead to a New Standard of Care for In Vitro Fertilization Treatment

New study results published in Human Reproduction could pave the way for an additional treatment option for the estimated 1.5 million women...


07 Mar, 2017, 09:00 ET Abbott Announces Results of Early Tenders and Consents in Exchange Offers and Execution of Supplemental Indenture

Abbott (NYSE: ABT) announced today that, as of 5:00 p.m. New York City time, on March 6, 2017, the aggregate principal amounts of each series of...


21 Feb, 2017, 08:55 ET Abbott Commences Exchange Offers and Consent Solicitations for St. Jude Medical, LLC Notes

Abbott (NYSE:ABT) announced today that it has commenced offers to exchange all validly tendered and accepted notes of the following series issued...


17 Feb, 2017, 11:25 ET Abbott Declares 373rd Consecutive Quarterly Dividend

The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 26.5 cents per share. This marks the 373rd consecutive...


15 Feb, 2017, 08:30 ET Real-World Data from Abbott's FreeStyle® Libre Show Association Between Higher Frequency of Glucose Monitoring and Improved Glucose Control for People with Diabetes

Abbott (NYSE: ABT) today announced the results of real-world use data[1] showing that people who scan more frequently using Abbott′s FreeStyle®...


02 Feb, 2017, 08:00 ET U.S. FDA Grants Abbott the First Commercial Authorization for a Molecular Test to Detect Zika Virus Using Whole Blood

Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has authorized its molecular test, the Abbott RealTime ZIKA...


01 Feb, 2017, 08:00 ET Abbott Announces U.S. Approval for its Assurity MRI™ Pacemaker, the World's Smallest, Longest-Lasting Wireless MRI-Compatible Pacemaker

Abbott (NYSE: ABT) today announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for both the...


25 Jan, 2017, 07:45 ET Abbott Reports Fourth-Quarter 2016 Results

Abbott (NYSE: ABT) today announced financial results for the fourth quarter ended Dec. 31, 2016. - Reported diluted EPS from continuing...


20 Jan, 2017, 18:00 ET New Study Demonstrates Spinal Cord Stimulation Can Reduce or Stabilize Opioid Use Among Chronic Pain Patients

New research has found spinal cord stimulation (SCS) therapy can be key to reducing or stabilizing the use of opioids in patients battling chronic...


18 Jan, 2017, 08:00 ET Abbott Announces European Launch of the Proclaim™ DRG Neurostimulation System for the Management of Chronic Neuropathic Pain

Abbott (NYSE: ABT) today announced the European launch of the new Proclaim™ DRG Neurostimulation System, designed to deliver dorsal root ganglion...


17 Jan, 2017, 08:00 ET New Data Confirms Abbott's Dorsal Root Ganglion Stimulation Offers Greater Treatment Success over Traditional Spinal Cord Stimulation

New data published in the January edition of Pain has confirmed the superiority of Abbott's dorsal root ganglion (DRG) stimulation therapy over...


12 Jan, 2017, 16:00 ET Abbott Announces U.S. Launch and First Commercial Use of the New EnSite™ Precision Cardiac Mapping System

Abbott (NYSE: ABT) announced today the U.S. launch and the first commercial uses of the new EnSite Precision™ cardiac mapping system and Advisor™...


11 Jan, 2017, 00:00 ET Abbott Obtient la Certification CE pour ses Systèmes de Diagnostic de la Série « Alinity ci »

LA NOUVELLE GÉNÉRATION DE SYSTÈMES HARMONISÉS, ASSOCIÉE AUX SERVICES PROFESSIONNELS ALINIQ LANCÉS RÉCEMMENT, APPORTENT UNE SOLUTION UNIQUE POUR...